Form 4: Eastman Chemical SVP Acquires Phantom Stock Units
Insider Transaction Report
Eastman Chemical's SVP, Chief HR Officer, Adrian James Holt, acquired 2,200 phantom stock units under an executive deferred compensation plan.
Summary
- Adrian James Holt, SVP, Chief HR Officer of Eastman Chemical Co (EMN), acquired 2,200 phantom stock units.
- The acquisition occurred on August 28, 2025.
- Each phantom stock unit has a value equal to one share of Eastman Chemical common stock.
- The units were acquired at a price of $68.18 per unit.
- These units are payable only in cash after termination of employment and are subject to certain acceleration and early withdrawal provisions.
- The acquisition was made under the Executive Deferred Compensation Plan.
- Following this transaction, Adrian James Holt beneficially owns 2,200 phantom stock units.
Sentiment
Score: 6
Explanation: Slightly positive due to executive alignment with company performance through deferred compensation, but it's a routine compensation event rather than a significant market signal.
Positives
- Acquisition of phantom stock units by a senior executive aligns their interests with shareholders, as the value is tied to the company's common stock performance.
- Participation in the Executive Deferred Compensation Plan indicates a commitment to long-term incentives for key management.
Negatives
- Phantom stock units are cash-settled and do not represent direct equity ownership, meaning the executive does not hold voting rights or direct share ownership.
Risks
- The value of the phantom stock units is subject to the future performance of Eastman Chemical's common stock.
- Payment is contingent on termination of employment and subject to specific plan provisions, which could affect liquidity or timing for the executive.
Future Outlook
NA
Industry Context
This is a routine insider transaction related to executive compensation, common across various industries for aligning executive incentives with company performance. It does not provide specific insights into broader industry trends for the chemical sector.
Stakeholder Impact
- Shareholders: The acquisition of phantom stock units by a senior executive can be viewed positively as it aligns management's long-term interests with shareholder value creation, as the units' value is tied to common stock performance.
- Employees: No direct impact on general employees.
Key Dates
| Date | Description |
|---|---|
| 08/28/2025 | Date of transaction for the acquisition of phantom stock units. |
| 08/29/2025 | Date the Form 4 was signed. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event involving the acquisition of phantom stock units. While it indicates management's alignment with long-term company performance, it does not provide new fundamental information or a significant catalyst to warrant a change in investment recommendation. The transaction is part of a deferred compensation plan and does not reflect a discretionary open-market purchase or sale that might signal a change in management's outlook on the stock's immediate prospects.
Keywords
Eastman Chemical, EMN, Phantom Stock Units, Executive Compensation, Insider Transaction, Deferred Compensation, Adrian James Holt, SVP, Chief HR Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.